Market Whales and Their Recent Bets on MRNA Options

MODERNA -0.58%

MODERNA

MRNA

101.41

-0.58%

Financial giants have made a conspicuous bullish move on Moderna. Our analysis of options history for Moderna (NASDAQ:MRNA) revealed 13 unusual trades.

Delving into the details, we found 53% of traders were bullish, while 46% showed bearish tendencies. Out of all the trades we spotted, 4 were puts, with a value of $131,905, and 9 were calls, valued at $371,568.

Predicted Price Range

Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $40.0 to $115.0 for Moderna over the recent three months.

Insights into Volume & Open Interest

Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Moderna's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Moderna's whale trades within a strike price range from $40.0 to $115.0 in the last 30 days.

Moderna Call and Put Volume: 30-Day Overview

Options Call Chart

Largest Options Trades Observed:

Symbol PUT/CALL Trade Type Sentiment Exp. Date Strike Price Total Trade Price Open Interest Volume
MRNA CALL SWEEP BULLISH 03/15/24 $110.00 $67.2K 1.7K 434
MRNA CALL TRADE BULLISH 04/05/24 $100.00 $62.0K 256 148
MRNA PUT SWEEP BULLISH 07/19/24 $95.00 $43.6K 847 67
MRNA CALL TRADE BEARISH 04/19/24 $105.00 $40.3K 2.4K 230
MRNA CALL SWEEP BEARISH 03/15/24 $98.00 $38.4K 844 124

About Moderna

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 39 mRNA development candidates in clinical trials as of mid-2023. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

Following our analysis of the options activities associated with Moderna, we pivot to a closer look at the company's own performance.

Present Market Standing of Moderna

  • Trading volume stands at 2,962,331, with MRNA's price down by 0.0%, positioned at $99.48.
  • RSI indicators show the stock to be may be approaching overbought.
  • Earnings announcement expected in 55 days.

What The Experts Say On Moderna

Over the past month, 3 industry analysts have shared their insights on this stock, proposing an average target price of $100.66666666666667.

  • An analyst from Canaccord Genuity has decided to maintain their Hold rating on Moderna, which currently sits at a price target of $91.
  • An analyst from HSBC has revised its rating downward to Reduce, adjusting the price target to $86.
  • In a cautious move, an analyst from RBC Capital downgraded its rating to Outperform, setting a price target of $125.

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Moderna options trades with real-time alerts from Benzinga Pro.

Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via